Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Aringer

Showing results (41-50 of 216) with videos related to

Pageof 22
Sort By:
Arthritis Research & Therapy|June 26, 2003
SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosusMartin Aringer, Josef S Smolen
Rheumatic Diseases Clinics of North America|July 3, 2021
Systemic Lupus Erythematosus Classification and DiagnosisMartin Aringer, Sindhu R Johnson
Current Opinion in Rheumatology|December 17, 2020
New lupus criteria: a critical viewMartin Aringer, Sindhu R Johnson
Zeitschrift Fur Rheumatologie|March 6, 2026
[Epidemiology and manifestations of Sjögren's disease]Martin Aringer, Anne-Kathrin Tausche
Rheumatology (Oxford, England)|December 6, 2020
Classifying and diagnosing systemic lupus erythematosus in the 21st centuryMartin Aringer, Sindhu R Johnson
Best Practice & Research. Clinical Rheumatology|December 11, 2007
Mixed connective tissue disease: what is behind the curtain?Martin Aringer, Josef S Smolen
Journal of Scleroderma and Related Disorders|April 6, 2022
Systemic sclerosis phase III clinical trials: Hope on the horizon?Martin Aringer, Christopher P Denton
Expert Opinion on Drug Safety|December 9, 2014
Safety of off-label biologicals in systemic lupus erythematosusMartin Aringer, Josef S Smolen
The New England Journal of Medicine|June 25, 2010
Mixed lymphohematopoietic chimerism and response in Wegener's granulomatosisMartin Bornhäuser, Martin Aringer, Christian Thiede
Clinical and Experimental Rheumatology|October 17, 2013
Withdrawal of therapy in non-renal systemic lupus erythematosus: is this an achievable goal?Marta Mosca, Chiara Tani, Martin Aringer
Pageof 22

Showing results (41-50 of 216) with videos related to

Sort By:
Pageof 22
Arthritis Research & Therapy|June 26, 2003
SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosusMartin Aringer, Josef S Smolen
Rheumatic Diseases Clinics of North America|July 3, 2021
Systemic Lupus Erythematosus Classification and DiagnosisMartin Aringer, Sindhu R Johnson
Current Opinion in Rheumatology|December 17, 2020
New lupus criteria: a critical viewMartin Aringer, Sindhu R Johnson
Zeitschrift Fur Rheumatologie|March 6, 2026
[Epidemiology and manifestations of Sjögren's disease]Martin Aringer, Anne-Kathrin Tausche
Rheumatology (Oxford, England)|December 6, 2020
Classifying and diagnosing systemic lupus erythematosus in the 21st centuryMartin Aringer, Sindhu R Johnson
Best Practice & Research. Clinical Rheumatology|December 11, 2007
Mixed connective tissue disease: what is behind the curtain?Martin Aringer, Josef S Smolen
Journal of Scleroderma and Related Disorders|April 6, 2022
Systemic sclerosis phase III clinical trials: Hope on the horizon?Martin Aringer, Christopher P Denton
Expert Opinion on Drug Safety|December 9, 2014
Safety of off-label biologicals in systemic lupus erythematosusMartin Aringer, Josef S Smolen
The New England Journal of Medicine|June 25, 2010
Mixed lymphohematopoietic chimerism and response in Wegener's granulomatosisMartin Bornhäuser, Martin Aringer, Christian Thiede
Clinical and Experimental Rheumatology|October 17, 2013
Withdrawal of therapy in non-renal systemic lupus erythematosus: is this an achievable goal?Marta Mosca, Chiara Tani, Martin Aringer
Pageof 22